Hunt for infectious causes of Alzheimer's gains momentum

Science (New York, N.Y.)
|August 1, 2024
PubMed

Insights

Researchers are investigating the direct causes linking infections to dementia. This research aims to understand how pathogens may trigger or accelerate neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Pathology

Background:

  • Dementia, a group of cognitive disorders, poses a significant global health challenge.
  • The etiology of many dementia types remains incompletely understood, with growing interest in infectious agents.
  • Pathogens are increasingly suspected to play a role in neuroinflammation and neurodegeneration.

Discussion:

  • Exploring the potential causal relationship between microbial pathogens and dementia development.
  • Examining how specific pathogens might trigger or accelerate neurodegenerative processes.
  • Assessing the evidence for infectious agents as contributing factors in various dementia types.

Key Insights:

  • Emerging research focuses on identifying specific pathogens implicated in dementia.
  • Studies are investigating the mechanisms by which pathogens may induce brain damage.
  • This work seeks to establish a definitive causal link between infections and dementia.

Outlook:

  • Potential for novel diagnostic markers based on pathogen detection.
  • Development of targeted therapies to prevent or treat dementia by addressing infectious causes.
  • Future research directions include longitudinal studies and advanced molecular techniques to confirm causality.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.5K